FibroGen Inc
NASDAQ:FGEN

Watchlist Manager
FibroGen Inc Logo
FibroGen Inc
NASDAQ:FGEN
Watchlist
Price: 8.43 USD -1.52% Market Closed
Market Cap: 34.1m USD

Wall Street
Price Targets

FGEN Price Targets Summary
FibroGen Inc

Wall Street analysts forecast FGEN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for FGEN is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.

Lowest
Price Target
43.43 USD
415% Upside
Average
Price Target
43.86 USD
420% Upside
Highest
Price Target
45.15 USD
436% Upside
FibroGen Inc Competitors:
Price Targets
PHIL
Philogen SpA
13% Upside
GOSS
Gossamer Bio Inc
193% Upside
LCTX
Lineage Cell Therapeutics Inc
167% Upside
UTHR
United Therapeutics Corp
2% Upside
FOLD
Amicus Therapeutics Inc
14% Upside
PEB
Pacific Edge Ltd
25% Downside
BCYC
Bicycle Therapeutics PLC
201% Upside
PTGX
Protagonist Therapeutics Inc
8% Upside

Revenue
Forecast

Revenue Estimate
FibroGen Inc

For the last 11 years the compound annual growth rate for FibroGen Inc's revenue is -11%. The projected CAGR for the next 4 years is -32%.

-11%
Past Growth
-32%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
FibroGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
18%
Average Beat

Net Income
Forecast

Net Income Estimate
FibroGen Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FGEN's stock price target?
Price Target
43.86 USD

According to Wall Street analysts, the average 1-year price target for FGEN is 43.86 USD with a low forecast of 43.43 USD and a high forecast of 45.15 USD.

What is FibroGen Inc's Revenue forecast?
Projected CAGR
-32%

For the last 11 years the compound annual growth rate for FibroGen Inc's revenue is -11%. The projected CAGR for the next 4 years is -32%.

Back to Top